Logex, an Amsterdam, Netherlands-based healthcare analytics company, received an investment from Thoma Bravo.
The amount of the deal was not disclosed. Existing shareholders, the company’s founders, and Summa Equity will remain invested with the business and will work closely with Thoma Bravo and the executive committee to support European growth and further drive innovation in healthcare analytics.
Founded in 2008 and led by CEO Philipp Jan Flach, Logex is a healthcare analytics provider which uses data to help healthcare providers and hospitals make decisions and deliver health outcomes for patients while reducing costs. The company currently serves over 700 of public and private healthcare providers and is active in ten countries with plans to further expand across Europe.
It has an international team of over 450 members.
FinSMEs
01/03/2023